In Review: Missouri begins its legislative session this week, and pre-filing has been underway for a month. PCMA has identified numerous bills of concern:
- SB 13 – relating to 340B, affiliate/steering, any willing pharmacy, biosimilar, white bagging
- HB 79 – alternative funding/patient assistance programs, copay accumulator, copay maximizer
- SB 187 – copay accumulator ban
- HB 186 – insulin coverage mandate, copay cap $100 for all supplies, regardless of quantity or type
- HB 79 – co-pay maximizer
- HB 309 – any willing provider
- HB 398 – contraceptive coverage mandate
- HB 487 – fertility coverage mandate
- SB 178 – contraceptive coverage mandate
- SB 308 – Co-Pay Ban
- SB 519 – Emergency Dispensing Authority
- SB 512 – Anti- PBM Omnibus
- SB 499 – Any Willing Provider
- SB 45 – Anti-PBM Omnibus
- HB 372 – Anti-PBM Omnibus
- SB 299 – Cost-sharing Restrictions
- SB 230 – Prior Authorization Restrictions
- SB 175 – Insulin Co-Pay Cap
- SB 158 – Opioid Alternatives Coverage Mandate
- HB 618 – Prior Authorization Restrictions
- HB 474 – Anti-PBM Omnibus
- HB 471 – Emergency Dispensing of Insulin
Up Next: PCMA will continue to monitor bill drafts as they are introduced.
If you have any questions, please contact Phil Christofanelli at pchristofanelli@pcmanet.org.